Atsushi Sugioka

Title: Atsushi Sugioka: Innovator in Antibody Research

Introduction

Atsushi Sugioka is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of antibody research, holding two patents that focus on innovative methods for classifying and identifying antibodies and antigens. His work is pivotal in advancing medical research and treatment options.

Latest Patents

Sugioka's latest patents include a method of classifying antibodies, a method of identifying antigens, and a method of obtaining antibodies or antibody sets. One of his notable inventions relates to isolated antibodies against HER1, CD147, CD73, and EpCAM. These antibodies are crucial for developing reagents and compositions that can be utilized in various medical applications. Additionally, he has developed an anti-IgSF4 antibody aimed at treating or diagnosing cancer, specifically targeting molecules expressed in lung cancer cells.

Career Highlights

Throughout his career, Sugioka has worked with reputable organizations such as Amano Enzyme Inc. and the Institute for Antibodies Co., Ltd. His experience in these companies has allowed him to refine his expertise in antibody research and development.

Collaborations

Sugioka has collaborated with notable colleagues, including Gene Kurosawa and Mariko Sumitomo. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Atsushi Sugioka is a distinguished inventor whose work in antibody research has the potential to impact cancer treatment significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.